ESMO Magnitude of Clinical Benefit Scale: News & Editorials

Keep up to date with the latest news and articles about the ESMO Magnitude of Clinical Benefit Scale

November 2016

Judging Cancer Drugs by Clinical, Not Statistical, Measures – Big Trials Aiming for Small Effects
Article published by Medscape, 4 November 2016 (You will need to be logged in to Medscape, but accounts are free.)

October 2016

First Feasibility Study of the ESMO-MCBS Scale in Rare Tumour Entities
ESMO Press Release published 10 October 2016

September 2016

Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
ESMO Press Release published 19 September 2016 introducing first eUpdate including ESMO-MCBS table

July 2016

Results of First Study Assessing Clinical Impact of ESMO-MCBS
ESMO Press Release published 7 July 2016

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
Authors: Barbara Kiesewetter, Markus Raderer, Günther G Steger, Rupert Bartsch, Robert Pirker, Sabine Zöchbauer-Müller, Gerald Prager, Michael Krainer, Matthias Preusser, Manuela Schmidinger, Christoph C Zielinski
Article published in ESMO Open, 4 July 2016

Applying the ESMO-Magnitude of Clinical Benefit Scale in Real Life
Authors: Fortunato Ciardiello, Josep Tabernero
Editorial published in ESMO Open, 4 July 2016

October 2015

Sizing Up ESMO's Drug Benefit Scale
David Kerr talks to Nathan Cherny about the scale
Video published by Medscape, 12 October 2015 (You will need to be logged in to Medscape, but accounts are free.)

June 2015

Proven Efficacy, Equitable Access and Adjusted Pricing of Anti-Cancer Therapies: No  ́Sweetheart ́ Solution
Author: Josep Tabernero on behalf of the ESMO Executive Board
Editorial published in Annals of Oncology, 4 June 2015

Citations and metrics